Literature DB >> 22865725

HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Yun Kyung Hahn1, Elizabeth M Podhaizer, Kurt F Hauser, Pamela E Knapp.   

Abstract

HIV-associated neurocognitive disorders (HANDs) are common sequelae of human immunodeficiency virus (HIV) infection, even when viral titers are well controlled by antiretroviral therapy. Evidence in patients and animal models suggests that neurologic deficits are increased during chronic opiate exposure. We have hypothesized that central nervous system (CNS) progenitor cells in both adult and developing CNS are affected by HIV infection and that opiates exacerbate these effects. To examine this question, neural progenitors were exposed to HIV-1 Tat(1-86) in the developing brain of inducible transgenic mice and in vitro. We examined whether Tat affected the proliferation or balance of progenitor populations expressing nestin, Sox2, and Olig2. Disease relevance was further tested by exposing human-derived progenitors to supernatant from HIV-1 infected monocytes. Studies concentrated on striatum, a region preferentially targeted by HIV and opiates. Results were similar among experimental paradigms. Tat or HIV exposure reduced the proliferation of undifferentiated (Sox2(+)) progenitors and oligodendroglial (Olig2(+)) progenitors. Coexposure to morphine exacerbated the effects of Tat or HIV-1(SF162) supernatant, but partially reversed HIV-1(IIIB) supernatant effects. Populations of Sox2(+) and Olig2(+) cells were also reduced by Tat exposure, although progenitor survival was unaffected. In rare instances, p24 immunolabeling was detected in viable human progenitors by confocal imaging. The vulnerability of progenitors is likely to distort the dynamic balance among neuron/glial populations as the brain matures, perhaps contributing to reports that neurologic disease is especially prevalent in pediatric HIV patients. Pediatric disease is atypical in developed regions but remains a serious concern in resource-limited areas where infection occurs commonly at birth and through breast feeding.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865725      PMCID: PMC4030306          DOI: 10.1002/glia.22403

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  130 in total

1.  Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells.

Authors:  Shunji Suzuki; Linda F Chuang; Peter Yau; Roy H Doi; Ronald Y Chuang
Journal:  Exp Cell Res       Date:  2002-11-01       Impact factor: 3.905

2.  NMDA receptor activation by HIV-Tat protein is clade dependent.

Authors:  Wenxue Li; Yan Huang; Rollie Reid; Joseph Steiner; Tanya Malpica-Llanos; Thomas A Darden; Susarla K Shankar; Anita Mahadevan; Parthasarthy Satishchandra; Avindra Nath
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

Review 3.  Neural stem cells in the developing and adult brains.

Authors:  Qiuhao Qu; Yanhong Shi
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 4.  HIV dementia and the basal ganglia.

Authors:  J R Berger; A Nath
Journal:  Intervirology       Date:  1997       Impact factor: 1.763

5.  Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses.

Authors:  P E Knapp; K Maderspach; K F Hauser
Journal:  Glia       Date:  1998-02       Impact factor: 7.452

6.  Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine.

Authors:  Marilyn J Duncan; Annadora J Bruce-Keller; Clayton Conner; Pamela E Knapp; Ruquiang Xu; Avindra Nath; Kurt F Hauser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-10       Impact factor: 3.619

Review 7.  The opioid-exposed newborn: assessment and pharmacologic management.

Authors:  Lauren M Jansson; Martha Velez; Cheryl Harrow
Journal:  J Opioid Manag       Date:  2009 Jan-Feb

8.  Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice.

Authors:  Kevin A Burns; Brian Murphy; Steve C Danzer; Chia-Yi Kuan
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

Review 9.  Molecular basis for interactions of HIV and drugs of abuse.

Authors:  Avi Nath; Kurt F Hauser; Valerie Wojna; Rosemarie M Booze; William Maragos; Mark Prendergast; Wayne Cass; Jadwiga T Turchan
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

10.  HIV-1 Tat and morphine have interactive effects on oligodendrocyte survival and morphology.

Authors:  Kurt F Hauser; Yun Kyung Hahn; Valeriya V Adjan; Shiping Zou; Shreya K Buch; Avindra Nath; Annadora J Bruce-Keller; Pamela E Knapp
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

View more
  22 in total

1.  Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.

Authors:  Joyce M Balinang; Ruturaj R Masvekar; Kurt F Hauser; Pamela E Knapp
Journal:  AIDS       Date:  2017-03-27       Impact factor: 4.177

2.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

3.  In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.

Authors:  Chaoran Yin; Ting Zhang; Xiying Qu; Yonggang Zhang; Raj Putatunda; Xiao Xiao; Fang Li; Weidong Xiao; Huaqing Zhao; Shen Dai; Xuebin Qin; Xianming Mo; Won-Bin Young; Kamel Khalili; Wenhui Hu
Journal:  Mol Ther       Date:  2017-03-30       Impact factor: 11.454

4.  Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.

Authors:  Yun Kyung Hahn; Ruturaj R Masvekar; Ruqiang Xu; Kurt F Hauser; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

5.  Involvement of extracellular signal-regulated kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure.

Authors:  Shaily Malik; Rinki Saha; Pankaj Seth
Journal:  J Neuroimmune Pharmacol       Date:  2014-01-28       Impact factor: 4.147

Review 6.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

7.  Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.

Authors:  Lynnae Schwartz; Sergei V Spitsin; John Meshki; Florin Tuluc; Steven D Douglas; John H Wolfe
Journal:  J Neurovirol       Date:  2013-06-14       Impact factor: 2.643

8.  Methamphetamine increases HIV infectivity in neural progenitor cells.

Authors:  Marta Skowronska; Marisa McDonald; Martina Velichkovska; Ana Rachel Leda; Minseon Park; Michal Toborek
Journal:  J Biol Chem       Date:  2017-11-20       Impact factor: 5.157

9.  Ecotropic Murine Leukemia Virus Infection of Glial Progenitors Interferes with Oligodendrocyte Differentiation: Implications for Neurovirulence.

Authors:  Ying Li; Jaclyn M Dunphy; Carlos E Pedraza; Connor R Lynch; Sandra M Cardona; Wendy B Macklin; William P Lynch
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

10.  Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.

Authors:  Shiping Zou; Babette Fuss; Sylvia Fitting; Yun Kyung Hahn; Kurt F Hauser; Pamela E Knapp
Journal:  J Neurosci       Date:  2015-08-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.